Sponsored diagnostic testing programs for Chronic Granulomatous Disease (CGD)
Chronic Granulomatous Disease (CGD) is an inherited immune disorder caused by defects in the NADPH oxidase complex, preventing neutrophils from effectively killing certain bacteria and fungi. This leads to recurrent, severe infections and granuloma formation in various organs.
2 programs found for Chronic Granulomatous Disease (CGD)
Invitae Unlock™ Immunology provides clinicians with a comprehensive gene panel to evaluate patients with suspected primary immunodeficiency or immune-regulatory disorders. This no-charge program supports diagnostic clarification, aids in variant-guided care decisions, and can inform family cascade testing when appropriate.
Invitae Unlock Immunology offers sponsored access to the Inborn Errors of Immunity and Cytopenias Panel, Invitae’s most comprehensive assay for evaluating inherited immune disorders and cytopenias. The panel includes genes tied to combined immunodeficiencies, immune dysregulation, and bone marrow failure, supporting clearer diagnosis and management. U.S. providers may order for eligible patients.
